These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 13842679)

  • 1. Treatment of Wilson's disease with penicillamine.
    WALSHE JM
    Lancet; 1960 Jan; 1(7117):188-92. PubMed ID: 13842679
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
    Neurology; 1962 Apr; 12():231-44. PubMed ID: 13899920
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of penicillamine as a diagnostic aid in hepatolenticular degeneration (Wilson's disease)].
    BLEHOVA B; HEYROVSKY L
    Cesk Pediatr; 1961 Sep; 16():809-11. PubMed ID: 13869965
    [No Abstract]   [Full Text] [Related]  

  • 4. [On Wilson's disease. Also a contribution on penicillamine therapy].
    LANGE J; HAGER H
    Z Kinderheilkd; 1960; 84():125-36. PubMed ID: 13853564
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
    LITIN RB; GOLDSTEIN NP; RANDALL RV; POWER MH; DIESSNER GR
    Neurology; 1960 Feb; 10():123-6. PubMed ID: 14417516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiopathological study of a case of Wilson's disease. Treatment with penicillamine].
    GREGOIRE F; TOUSSAINT D; VIS H; GREGOIRE PE
    Acta Clin Belg; 1960; 15():532-46. PubMed ID: 13708400
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
    Trans Am Neurol Assoc; 1961; 86():131-4. PubMed ID: 13899919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Essential hepatorenal form of Wilson's disease in a brother and a sister and its treatment with penicillamine].
    MONNET P; GAUTHIER J; COTTE J; VALLON JJ; NICOLAS A; RUITTON UGLIENGO
    Pediatrie; 1961; 16():565-81. PubMed ID: 13772042
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillamine, a new oral therapy for Wilson's disease.
    WALSHE JM
    Am J Med; 1956 Oct; 21(4):487-95. PubMed ID: 13362281
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning].
    SEIGNETTE WT; HAANEN CA; JANSEN AP; MAJOOR CL
    Folia Med Neerl; 1959 Jun; 2():65-78. PubMed ID: 14444631
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
    Berry WR; Aronson AE; Darley FL; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
    [No Abstract]   [Full Text] [Related]  

  • 13. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.
    Durand F; Bernuau J; Giostra E; Mentha G; Shouval D; Degott C; Benhamou JP; Valla D
    Gut; 2001 Jun; 48(6):849-52. PubMed ID: 11358907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic Wilson's disease in 2 patients using plasmapheresis--clinico-biochemical observations].
    Milovanović DD; Tomasević R; Bogdanović G
    Srp Arh Celok Lek; 1998; 126(9-10):327-34. PubMed ID: 9863403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic approaches to Wilson's disease].
    Meiner Z
    Harefuah; 1990 Mar; 118(5):296-8. PubMed ID: 2344986
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM
    Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE NEPHROTIC SYNDROME AS A COMPLICATION OF PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
    HIRSCHMAN SZ; ISSELBACHER KJ
    Ann Intern Med; 1965 Jun; 62():1297-300. PubMed ID: 14295512
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.